CAPITAL RAISING

Unlike classical CFOs that are more finance controllers, we work as strategic CFO and Advisor to the CEO.

VALUATION:

Combining narratives with numbers and working with key opinion leaders and experts at different disease area provide us with qualitative insights to ensure high quality evaluation of early stage assets.

We operate across Europe in several countries

Although headquartered in Barcelona, Spain, we operate across Europe in several countries.

Sometimes, we do partner with local experts to leverage the local language, culture and other soft factors that are relevant for doing business in these countries.

Testimonials

Attgeno

Farmantra has helped us to evaluate the market potential and value of our new drug aimed for treatment of pulmonary hypertension. We are truly impressed by their work which they manage to deliver in a very efficient way and under stressed condition. Farmantra has also provided excellent advice on how to best capitalize our company and their reports has been appreciated by our investors. We highly recommend Farmantra.

Per Agvald

CEO, Attgeno

SOM-Biotech

“Farmantra has an intelligent proactive team able to quickly and accurately understand the needs of a biotechnology company, while at the same time offer seriousness, confidence and security. Having the opportunity to work with someone of the caliber of Farmantra is a true privilege”

Raúl Insa

Founder and CEO , SOM Biotech

Bionanoplus

Farmantra was assigned the challenging task of evaluating the strategic path Bionanoplus should take as we were operational in several sectors and areas. Farmantra team along with their experts did an excellent job in doing the following:

– Segregating short and long term strategies

– Identifying areas where Bionanoplus should focus on based on resources and capabilities we have

– Advising on right capital structure by assessing the value creation if we raise equity vs if we do not

– Focusing on areas and expertise that could create long term value for the shareholders

In sum, their analysis allowed us to make decisions and this is what any CEO needs to make especially in our life sciences sector that is beset with several risks and uncertainties. If you are looking at getting a high quality analysis on your strategic considerations with a financial perspective, go for it.

Hesham Salman

CEO, Bionanoplus

Molomics

Farmantra did a great job in profesionalizing our financial plan. Amongst their work were, for example, very strong market studies, detailed risk simulations, what assets we should prioritize, a strong financing strategy, etc.. Thanks to Farmantra, we have a very good roadmap to maximise the company’s value. Their work has already helped us to pass a financial due diligence. In summary, we highly recommend Farmantra for any work related to Finance.

Jascha Blobel

CEO, Molomics

AB Biotics

In order to outlicense our pro-biotic product AB-Life, Farmantra was chosen by our management team for the Indian market. We are pleased to say that they not only explored Indian market but also other markets such as Egypt , Bangladesh etc.

Farmantra delivered excellent results with a very high standard of professionalism. Their approach not only speaks of their well-developed skills but also of their ability to identify and overcome key barriers to the success of the project. Without a doubt we will use their services again for future ventures.

Miquel Angel Bonachera

CEO, AB-Biotics

Banc de sang i teixits

Last year, we decided to work on internationalization of Xcelia, Division of Advanced Therapies Blood and Tissue Bank of Barcelona. After analyzing various strategic options, India was chosen to be one of the countries to explore.

Farmantra was unanimously recommended by several professionals for their professionalism, knowledge of Indian markets, strong management team, pro-activeness and cultural adaptability to India and Spain.

Today, after working together with Farmantra for many months since they accepted the challenging project, we are dealing with real potential success, discussing with several potential candidates for licensing /co-development. During this time, progress has been steady, efficient, professional and above all honest.